OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
Status:
Completed
Trial end date:
2018-11-30
Target enrollment:
Participant gender:
Summary
This is a phase 2, multi-center, single dose, open-label, exploratory study in suspected lung
cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/positron emission
tomography imaging based on standard of care. This study aims to assess the efficacy of OTL38
and Near Infrared Imaging (NIR) at identifying pulmonary nodules within the operating
theater, and to assess the safety and tolerability of single intravenous doses of OTL38.